Evidence for Bisphenol B Endocrine Properties: Scientific and Regulatory Perspectives
The substitution of bisphenol A (BPA) by bisphenol B (BPB), a very close structural analog, stresses the need to assess its potential endocrine properties. This analysis aimed to investigate whether BPB has endocrine disruptive properties in humans and in wildlife as defined by the World Health Orga...
Saved in:
Published in | Environmental health perspectives Vol. 127; no. 10; p. 106001 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
National Institute of Environmental Health Sciences
01.10.2019
EDP Sciences Environmental Health Perspectives |
Subjects | |
Online Access | Get full text |
ISSN | 0091-6765 1552-9924 0767-0974 1552-9924 1958-5381 |
DOI | 10.1289/EHP5200 |
Cover
Summary: | The substitution of bisphenol A (BPA) by bisphenol B (BPB), a very close structural analog, stresses the need to assess its potential endocrine properties.
This analysis aimed to investigate whether BPB has endocrine disruptive properties in humans and in wildlife as defined by the World Health Organization (WHO) definition used in the regulatory field, that is,
) adverse effects,
) endocrine activity, and
) plausible mechanistic links between the observed endocrine activity and adverse effects.
We conducted a systematic review to identify BPB adverse effects and endocrine activities by focusing on animal models and
mechanistic studies. The results were grouped by modality (estrogenic, androgenic, thyroid hormone, steroidogenesis-related, or other endocrine activities). After critical analysis of results, lines of evidence were built using a weight-of-evidence approach to establish a biologically plausible link. In addition, the ratio of BPA to BPB potency was reported from studies investigating both bisphenols.
Among the 36 articles included in the analysis, 3 subchronic studies consistently reported effects of BPB on reproductive function. In rats, the 28-d and 48-week studies showed alteration of spermatogenesis associated with a lower height of the seminiferous tubules, the alteration of several sperm parameters, and a weight loss for the testis, epididymis, and seminal vesicles. In zebrafish, the results of a 21-d reproductive study demonstrated that exposed fish had a lower egg production and a lower hatching rate and viability. The
and
mechanistic data consistently demonstrated BPB's capacity to decrease testosterone production and to exert an estrogenic-like activity similar to or greater than BPA's, both pathways being potentially responsible for spermatogenesis impairment in rats and fish.
The available
,
, and
data, although limited, coherently indicates that BPB meets the WHO definition of an endocrine disrupting chemical currently used in a regulatory context. https://doi.org/10.1289/EHP5200. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Review-3 content type line 23 |
ISSN: | 0091-6765 1552-9924 0767-0974 1552-9924 1958-5381 |
DOI: | 10.1289/EHP5200 |